SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
6,968,421
Share change
+2,580,393
Total reported value
$83,963,374
Price per share
$12.05
Number of holders
49
Value change
+$31,119,980
Number of buys
35
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q3 2018

As of 30 Sep 2018, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,968,421 shares. The largest 10 holders included BVF INC/IL, ADAGE CAPITAL PARTNERS GP, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Vanguard Group Inc, TIEDEMANN ADVISORS, LLC, AXA, Sectoral Asset Management Inc, and PARSONS CAPITAL MANAGEMENT INC/RI. This page lists 49 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.